In the wild-type group, profibrotic mediators, TGF-β1 and TIMP-1 were increased after bleomycin compared to the levels monitored in naive conditions; changes after challenge were more pronounced in CF (Figure 1e,f). Here, TGFB1 is linked to cystic fibrosis.